(Q51790677)

12 April 2018

title

Mutation of keratin 8 in patients with liver disease. (English)

1 reference

12 April 2018

author name string

Maximilian Schöniger-Hekele

series ordinal

1

1 reference

12 April 2018

Dagmar Petermann

series ordinal

2

1 reference

12 April 2018

Christian Müller

series ordinal

3

1 reference

12 April 2018

publication date

1 September 2006

1 reference

12 April 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

12 April 2018

volume

21

1 reference

12 April 2018

issue

9

1 reference

12 April 2018

page(s)

1466-1469

1 reference

12 April 2018

cites work

Mallory bodies revisited

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Keratins: guardians of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

The keratin cytoskeleton in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

A structural scaffolding of intermediate filaments in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Keratin 8 mutations in patients with cryptogenic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Keratin 8 Y54H and G62C mutations are not associated with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

Keratin mutations and intestinal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

A frequent keratin 8 p.L227L polymorphism, but no point mutations in keratin 8 and 18 genes, in patients with various liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04392.X

10.1111/J.1440-1746.2006.04392.X

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018